Pandemic Preparedness Vaccines
Pandemic Influenza (e.g., H5N1)
Clinical DevelopmentActive (for stockpiling)
Key Facts
Indication
Pandemic Influenza (e.g., H5N1)
Phase
Clinical Development
Status
Active (for stockpiling)
Company
About CSL Seqirus
CSL Seqirus is a mission-driven global leader in influenza vaccines, leveraging its position within the CSL Limited ecosystem to advance public health. Its strategy is built on a diversified technology platform, a broad product portfolio, and a robust global manufacturing footprint. The company plays a pivotal role in seasonal flu prevention and is a key partner to governments worldwide for pandemic response, underpinned by continuous R&D and strategic in-licensing.
View full company profile